<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="blood"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3567337/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genome-wide study of methotrexate clearance replicates SLCO1B1</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567337/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Blood"><meta name="citation_title" content="Genome-wide study of methotrexate clearance replicates SLCO1B1"><meta name="citation_authors" content="Laura B. Ramsey, John C. Panetta, Colton Smith, Wenjian Yang, Yiping Fan, Naomi J. Winick, Paul L. Martin, Cheng Cheng, Meenakshi Devidas, Ching-Hon Pui, William E. Evans, Stephen P. Hunger, Mignon Loh, Mary V. Relling"><meta name="citation_date" content="7 February 2013"><meta name="citation_issue" content="6"><meta name="citation_volume" content="121"><meta name="citation_firstpage" content="898"><meta name="citation_doi" content="10.1182/blood-2012-08-452839"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3567337/?report=abstract"><meta name="citation_pmid" content="23233662"><meta name="DC.Title" content="Genome-wide study of methotrexate clearance replicates SLCO1B1"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="The American Society of Hematology"><meta name="DC.Contributor" content="Laura B. Ramsey"><meta name="DC.Contributor" content="John C. Panetta"><meta name="DC.Contributor" content="Colton Smith"><meta name="DC.Contributor" content="Wenjian Yang"><meta name="DC.Contributor" content="Yiping Fan"><meta name="DC.Contributor" content="Naomi J. Winick"><meta name="DC.Contributor" content="Paul L. Martin"><meta name="DC.Contributor" content="Cheng Cheng"><meta name="DC.Contributor" content="Meenakshi Devidas"><meta name="DC.Contributor" content="Ching-Hon Pui"><meta name="DC.Contributor" content="William E. Evans"><meta name="DC.Contributor" content="Stephen P. Hunger"><meta name="DC.Contributor" content="Mignon Loh"><meta name="DC.Contributor" content="Mary V. Relling"><meta name="DC.Date" content="2013 Feb 7"><meta name="DC.Identifier" content="10.1182/blood-2012-08-452839"><meta name="DC.Language" content="en"><meta property="og:title" content="Genome-wide study of methotrexate clearance replicates SLCO1B1"><meta property="og:type" content="article"><meta property="og:description" content="Methotrexate clearance can influence the cure of and toxicity in children with acute lymphoblastic leukemia (ALL). We estimated methotrexate plasma clearance for 1279 patients with ALL treated with methotrexate (24-hour infusion of a 1 g/m[2]  dose or ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567337/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-blood.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3567337/epub/">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8A4BB9DD54B74100000000073204BE.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/extensions/MathEvents.js?rev=2.6.1"></script><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/extensions/MathZoom.js?rev=2.6.1"></script><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/extensions/MathMenu.js?rev=2.6.1"></script><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3567337%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="mesh">MeSH</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=%22Blood%22[journal]" class="navlink">Blood</a></li><li class="accid">PMC3567337</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-blood.gif" alt="Logo of blood" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="139,56,200,76" alt="Original Article" title="Original Article" href="http://www.bloodjournal.org/content/121/6/898" ref="reftype=publisher&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7CArticle%7CFullText" target="pmc_ext"><area shape="rect" coords="0,0,157,57" alt="Blood Journal" title="Blood Journal" href="http://www.bloodjournal.org/" ref="reftype=publisher&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="200,56,258,76" alt="Current Issue" title="Current Issue" href="http://www.bloodjournal.org/content/current" ref="reftype=publisher&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="257,56,311,76" alt="About Blood" title="About Blood" href="http://www.bloodjournal.org/page/about-blood" ref="reftype=publisher&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="309,56,364,77" alt="Submissions" title="Submissions" href="https://submit.bloodjournal.org/" ref="reftype=publisher&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="363,56,420,78" alt="Subscriptions" title="Subscriptions" href="http://www.bloodjournal.org/page/subscriptions" ref="reftype=publisher&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="418,56,476,76" alt="Contact Us" title="Contact Us" href="http://bloodjournal.org" ref="reftype=publisher&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="poly" coords="450,2,431,9,425,27,429,43,437,54,459,55,471,52,483,42,486,29,479,11,466,2,449,2" alt="ASH Homepage" title="ASH Homepage" href="http://www.hematology.org" ref="reftype=publisher&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Blood</a></span>. 2013 Feb 7; 121(6): 898–904. </span></div><div><span class="fm-vol-iss-date">Prepublished online 2012 Dec 11. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1182%2Fblood-2012-08-452839" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1182/blood-2012-08-452839</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3567337</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/23233662">23233662</a></div></div></div></div><h1 class="content-title">Genome-wide study of methotrexate clearance replicates <em>SLCO1B1</em></h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Ramsey%20LB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360862982240" co-class="co-affbox">Laura B. Ramsey</a>,<sup>1</sup> <a href="/pubmed/?term=Panetta%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360865221024" co-class="co-affbox">John C. Panetta</a>,<sup>1</sup> <a href="/pubmed/?term=Smith%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360937198896" co-class="co-affbox">Colton Smith</a>,<sup>1</sup> <a href="/pubmed/?term=Yang%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360935839504" co-class="co-affbox">Wenjian Yang</a>,<sup>1</sup> <a href="/pubmed/?term=Fan%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360935342336" co-class="co-affbox">Yiping Fan</a>,<sup>2</sup> <a href="/pubmed/?term=Winick%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360935340352" co-class="co-affbox">Naomi J. Winick</a>,<sup>3</sup> <a href="/pubmed/?term=Martin%20PL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360868424432" co-class="co-affbox">Paul L. Martin</a>,<sup>4</sup> <a href="/pubmed/?term=Cheng%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360864271440" co-class="co-affbox">Cheng Cheng</a>,<sup>5</sup> <a href="/pubmed/?term=Devidas%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360860296720" co-class="co-affbox">Meenakshi Devidas</a>,<sup>6</sup> <a href="/pubmed/?term=Pui%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360858955776" co-class="co-affbox">Ching-Hon Pui</a>,<sup>7</sup> <a href="/pubmed/?term=Evans%20WE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360858953792" co-class="co-affbox">William E. Evans</a>,<sup>1</sup> <a href="/pubmed/?term=Hunger%20SP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360864508752" co-class="co-affbox">Stephen P. Hunger</a>,<sup>8</sup> <a href="/pubmed/?term=Loh%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360935412768" co-class="co-affbox">Mignon Loh</a>,<sup>9</sup> and  <a href="/pubmed/?term=Relling%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662" class="affpopup" co-rid="_co_idm140360862799872" co-class="co-affbox">Mary V. Relling</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140360862982240"><h3 class="no_margin">Laura B. Ramsey</h3><p><sup>1</sup>Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Ramsey%20LB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">Laura B. Ramsey</a></div></div><div id="_co_idm140360865221024"><h3 class="no_margin">John C. Panetta</h3><p><sup>1</sup>Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Panetta%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">John C. Panetta</a></div></div><div id="_co_idm140360937198896"><h3 class="no_margin">Colton Smith</h3><p><sup>1</sup>Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Smith%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">Colton Smith</a></div></div><div id="_co_idm140360935839504"><h3 class="no_margin">Wenjian Yang</h3><p><sup>1</sup>Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Yang%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">Wenjian Yang</a></div></div><div id="_co_idm140360935342336"><h3 class="no_margin">Yiping Fan</h3><p><sup>2</sup>Department of Computational Biology, St Jude Children's Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Fan%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">Yiping Fan</a></div></div><div id="_co_idm140360935340352"><h3 class="no_margin">Naomi J. Winick</h3><p><sup>3</sup>Department of Pediatric Neuro-Oncology, University of Texas Southwestern Medical Center, Dallas, TX; </p><div>Find articles by <a href="/pubmed/?term=Winick%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">Naomi J. Winick</a></div></div><div id="_co_idm140360868424432"><h3 class="no_margin">Paul L. Martin</h3><p><sup>4</sup>Department of Pediatric Blood and Marrow Transplantation, Duke University Medical Center, Durham, NC; </p><div>Find articles by <a href="/pubmed/?term=Martin%20PL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">Paul L. Martin</a></div></div><div id="_co_idm140360864271440"><h3 class="no_margin">Cheng Cheng</h3><p><sup>5</sup>Department of Biostatistics, St Jude Children's Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Cheng%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">Cheng Cheng</a></div></div><div id="_co_idm140360860296720"><h3 class="no_margin">Meenakshi Devidas</h3><p><sup>6</sup>Children's Oncology Group Statistics and Data Center and the University of Florida, Gainesville, FL; </p><div>Find articles by <a href="/pubmed/?term=Devidas%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">Meenakshi Devidas</a></div></div><div id="_co_idm140360858955776"><h3 class="no_margin">Ching-Hon Pui</h3><p><sup>7</sup>Department of Oncology, St Jude Children's Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Pui%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">Ching-Hon Pui</a></div></div><div id="_co_idm140360858953792"><h3 class="no_margin">William E. Evans</h3><p><sup>1</sup>Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Evans%20WE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">William E. Evans</a></div></div><div id="_co_idm140360864508752"><h3 class="no_margin">Stephen P. Hunger</h3><p><sup>8</sup>University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO; and </p><div>Find articles by <a href="/pubmed/?term=Hunger%20SP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">Stephen P. Hunger</a></div></div><div id="_co_idm140360935412768"><h3 class="no_margin">Mignon Loh</h3><p><sup>9</sup>Oncology Clinic, University of California, San Francisco, San Francisco, CA</p><div>Find articles by <a href="/pubmed/?term=Loh%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">Mignon Loh</a></div></div><div id="_co_idm140360862799872"><h3 class="no_margin">Mary V. Relling</h3><p><sup>1</sup>Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Relling%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23233662">Mary V. Relling</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140360938707744_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140360938707744_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140360938707744_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140360938707744_ai" style="display:none"><div class="fm-affl" id="aff1" lang="en"><sup>1</sup>Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN; </div><div class="fm-affl" id="aff2" lang="en"><sup>2</sup>Department of Computational Biology, St Jude Children's Research Hospital, Memphis, TN; </div><div class="fm-affl" id="aff3" lang="en"><sup>3</sup>Department of Pediatric Neuro-Oncology, University of Texas Southwestern Medical Center, Dallas, TX; </div><div class="fm-affl" id="aff4" lang="en"><sup>4</sup>Department of Pediatric Blood and Marrow Transplantation, Duke University Medical Center, Durham, NC; </div><div class="fm-affl" id="aff5" lang="en"><sup>5</sup>Department of Biostatistics, St Jude Children's Research Hospital, Memphis, TN; </div><div class="fm-affl" id="aff6" lang="en"><sup>6</sup>Children's Oncology Group Statistics and Data Center and the University of Florida, Gainesville, FL; </div><div class="fm-affl" id="aff7" lang="en"><sup>7</sup>Department of Oncology, St Jude Children's Research Hospital, Memphis, TN; </div><div class="fm-affl" id="aff8" lang="en"><sup>8</sup>University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO; and </div><div class="fm-affl" id="aff9" lang="en"><sup>9</sup>Oncology Clinic, University of California, San Francisco, San Francisco, CA</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140360938707744_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2012 Aug 27; Accepted 2012 Nov 20.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140360938707744_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> © 2013 by The American Society of Hematology</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC3567337/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">
Supplemental Data, Tables, and Figures
</div>

<div><a href="/pmc/articles/PMC3567337/bin/supp_121_6_898__index.html" data-ga-action="click_feat_suppl">supp_121_6_898__index.html</a><span style="color:gray"> (839 bytes)</span></div><div class="small guid">GUID:&nbsp;824364E5-B560-44B7-9CB4-60BEFFC39816</div>
<div><a href="/pmc/articles/PMC3567337/bin/supp_blood-2012-08-452839_Document1.pdf" data-ga-action="click_feat_suppl">supp_blood-2012-08-452839_Document1.pdf</a><span style="color:gray"> (1.6M)</span></div><div class="small guid">GUID:&nbsp;89EFFB31-2BBD-44F9-93C2-24918FDE7F54</div>
</div></dd></dl></div><div id="idm140360869786512" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140360869786512title">Key Points</h2><!--article-meta--><div><ul class="unordered" style="list-style-type:disc"><!--
list-behavior=unordered
prefix-word=
mark-type=disc
max-label-size=0
--><li><p id="__p2">A genome-wide study of the association of over 5 million SNPs with methotrexate clearance in 1279 patients treated with HDMTX in multicenter COG trials 9904 and 9905.</p></li><li><p id="__p3">We replicated the finding that inherited variations in <em>SLCO1B1</em> are the most important genetic variations influencing methotrexate clearance.</p></li></ul><p></p></div></div><div id="idm140360868939904" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140360868939904title">Abstract</h2><!--article-meta--><div><p id="__p4" class="p p-first-last">Methotrexate clearance can influence the cure of and toxicity in children with acute lymphoblastic leukemia (ALL). We estimated methotrexate plasma clearance for 1279 patients with ALL treated with methotrexate (24-hour infusion of a 1 g/m<sup>2</sup> dose or 4-hour infusion of a 2 g/m<sup>2</sup> dose) on the Children's Oncology Group P9904 and P9905 protocols. Methotrexate clearance was lower in older children (<em>P</em> = 7 × 10<sup>−7</sup>), girls (<em>P</em> = 2.7 × 10<sup>−4</sup>), and those who received a delayed-intensification phase (<em>P</em> = .0022). A genome-wide analysis showed that methotrexate clearance was associated with polymorphisms in the organic anion transporter gene <em>SLCO1B1</em> (<em>P</em> = 2.1 × 10<sup>−11</sup>). This replicates findings using different schedules of high-dose methotrexate in St Jude ALL treatment protocols; a combined meta-analysis yields a <em>P</em> value of 5.7 × 10<sup>−19</sup> for the association of methotrexate clearance with <em>SLCO1B1</em> SNP rs4149056. Validation of this variant with 5 different treatment regimens of methotrexate solidifies the robustness of this pharmacogenomic determinant of methotrexate clearance. This study is registered at <a href="http://www.clinicaltrials.gov" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://www.clinicaltrials.gov</a> as <a id="__tag_545487848" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00005585" ref="reftype=extlink-clinical-trial&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00005585","term_id":"NCT00005585"}}</span>NCT00005585</a> and <a id="__tag_545487847" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00005596" ref="reftype=extlink-clinical-trial&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00005596","term_id":"NCT00005596"}}</span>NCT00005596</a>.</p></div></div><div id="__sec1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec1title">Introduction</h2><p id="__p5" class="p p-first-last">High-dose methotrexate (HDMTX) is an important element of chemotherapy in the treatment of acute lymphoblastic leukemia (ALL) and other malignancies.<sup><a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209683">1</a><a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209703"></a><a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209686"></a>–<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209676">4</a></sup> Mikkelsen et al<sup><a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209725">5</a></sup> showed that a 1 g/m<sup>2</sup> dose given over 24 hours resulted in significantly greater active methotrexate polyglutamates in leukemic cells than the same dose given over 4 hours. In a randomized clinical trial, investigators from the Children's Oncology Group (COG) tested the efficacy and toxicity of a 2 g/m<sup>2</sup> dose over 4 hours versus a 1 g/m<sup>2</sup> dose over 24 hours.<sup><a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209717">6</a>,<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209732">7</a></sup> The systemic exposure to methotrexate (ie, plasma concentration over time) is related to cure and toxicity in children with ALL.<sup><a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209687">8</a>,<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209695">9</a></sup> In a group of children with ALL who were treated and monitored at a single institution (St Jude Children's Research Hospital), with extensive prospective therapeutic drug monitoring, even including pharmacokinetically guided dosage adjustments, we identified variants in the <em>SLCO1B1</em> gene that were associated with methotrexate clearance in a genome-wide association study (GWAS).<sup><a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209729">10</a>,<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209685">11</a></sup> Herein, we sought to test whether we could replicate these GWAS findings in a large cohort of patients treated with alternative HDMTX schedules on the COG multi-institutional trials P9904 and P9905.</p></div><div id="__sec2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec2title">Methods</h2><p id="__p6" class="p p-first">This study was approved by the institutional review boards of all participating institutions, and informed consent was obtained in accordance with the Declaration of Helsinki. Patients in P9904 included National Cancer Institute (NCI) standard-risk (age 1.00-9.99 years and initial white blood cell count [WBC]&lt; 50 000/μL) patients with an <em>ETV6-RUNX1</em> translocation or simultaneous trisomies of chromosomes 4 and 10, whereas patients in P9905 included a mixture of NCI standard-risk patients without favorable genetic lesions, NCI high-risk (age ≥ 10 years and/or initial WBC ≥ 50 000/μL) patients with favorable genetic changes, and other NCI high-risk patients who did not meet age-, WBC-, and sex-specific criteria for especially high-risk disease originally described by Borowitz et al<sup><a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209704">6</a></sup> and Shuster et al.<sup><a href="#B12" rid="B12" class=" bibr popnode">12</a></sup> Patients were randomized in a 2 × 2 manner to 1 of 4 arms for consolidation: (A) 24-hour methotrexate infusion (1 g/m<sup>2</sup> given as a 200 mg/m<sup>2</sup> bolus over 20 minutes, followed by 800 mg/m<sup>2</sup> over 23.6 hours) and no delayed intensification (DI) phase; (B) 4-hour methotrexate infusion (2 g/m<sup>2</sup>) with no DI; (C) 24-hour methotrexate infusion with DI; and (D) 4-hour methotrexate infusion with DI. Leucovorin at 10 mg/m<sup>2</sup> was given every 6 hours (3 doses), beginning at 42 hours after the start of the infusion and continued until the plasma methotrexate level was less than 0.2μM. Plasma methotrexate concentrations were requested to be drawn at the end of infusion (4 or 24 hours) and 24 hours later (postinfusion), and leucovorin was increased based on plasma methotrexate concentration (details in supplemental Methods, available on the <em>Blood</em> Web site; see the Supplemental Materials link at the top of the online article). All patients with t(1;19)(q23;p13) were in P9905 as a separate stratum—all were assigned to receive a DI phase and randomized to arms C or D for the methotrexate infusion. Patients with simultaneous trisomies of chromosomes 4 and 10 all were assigned to receive no DI and randomized to arms A or B for the methotrexate infusion. Patients who did not respond to induction chemotherapy were not eligible.</p><p id="__p7">Data were retrieved from the COG Statistical and Data Center research databases. Of the 1883 patients treated with HDMTX on P9904 and P9905, 1588 were eligible and had germline DNA evaluable.<sup><a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209712">6</a></sup> Patients who had congenital abnormalities (usually Down syndrome, which is known to affect methotrexate clearance)<sup><a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209723">13</a><a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209706"></a>–<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209713">15</a></sup> or who did not have any courses that passed methotrexate quality control were excluded (<a href="/pmc/articles/PMC3567337/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). Demographic information on the patients included can be found in supplemental Table 1. Although participating institutions in COG P9904/9905 were asked to submit data on plasma methotrexate concentrations, the data had not previously undergone any analysis or quality control. Therefore, it was necessary to establish a quality control approach to exclude courses with implausible data; for example, courses with undetectable plasma concentrations of methotrexate at the end of infusion were considered implausible and likely due to errors in drawing samples or in data entry. Courses with only 1 sample were excluded, as were courses for which the concentration of the postinfusion sample (28 or 48 hours) was greater than the end of infusion sample (4 or 24 hours). In addition, samples were removed that fell outside the expected 1-99th percentile range of methotrexate concentrations predicted with the use of the methotrexate pharmacokinetic parameters observed in nearly 500 prospectively monitored patients from St Jude's Total XV study (supplemental Table 2).<sup><a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209709">10</a>,<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209721">16</a></sup></p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3567337/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140360862583952" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is zh89991301740001.jpg" title="An external file that holds a picture, illustration, etc.
Object name is zh89991301740001.jpg" src="/pmc/articles/PMC3567337/bin/zh89991301740001.jpg"></div></a><div id="largeobj_idm140360862583952" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC3567337/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a target="object" href="/pmc/articles/PMC3567337/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3567337/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p8"><strong>Flow chart of patients included in this analysis.</strong> A total of 1883 patients were treated with HDMTX on P9904 and P9905, and 1588 were eligible and had germline DNA evaluable. Patients who had congenital abnormalities (usually Down syndrome) were excluded because they may not have received the full methotrexate dose. Patients with implausible or no evaluable methotrexate plasma concentrations were excluded (see “Methods” for details).</p></div></div></div><p id="__p9">In practice, this step resulted in the following: for the 24-hour infusion arms, end of infusion samples less than 2μM or greater than 38.5μM were excluded, and 48-hour samples greater than 7.5μM were excluded; for the 4-hour infusion arms, end of infusion samples less than 25μM or greater than 310μM were excluded, and 28-hour samples greater than 25μM were excluded. Low postinfusion samples were not excluded because they were considered plausible, whereas undetectable concentrations at the end of infusion (<a href="/pmc/articles/PMC3567337/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>) must be related to sampling or data entry errors. Thus, 252 of 4205 24-hour infusion courses (15 of 730 patients) and 653 of 4277 4-hour infusion courses (39 of 749 patients) were excluded on the basis of implausible pharmacokinetic data (likely due to data entry or sample acquisition error; <a href="/pmc/articles/PMC3567337/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>). Overall, the median clearance for all courses after excluding the outliers was similar to the median clearance prior to excluding the outliers (144.6 vs 141.2 mL/min/m<sup>2</sup> for the 4-hour and 162.5 vs 162.3 mL/min/m<sup>2</sup> for the 24-hour infusions).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3567337/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140360861580224" class="figure"><a href="/pmc/articles/PMC3567337/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3567337_zh89991301740002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is zh89991301740002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3567337/bin/zh89991301740002.jpg"></a></div><div id="largeobj_idm140360861580224" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3567337/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3567337/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p10"><strong>Concentration versus time plots.</strong> (A) Twenty-four-hour methotrexate infusion of 1 g/m<sup>2</sup>. Concentrations shown were scheduled to be drawn at 24 hours (end of infusion) and at 48 hours (data are jittered [horizontal offset added] for better visualization). The pink lines represent the cut-offs (based on the range of the St Jude pharmacokinetic simulation) outside of which samples were excluded. There is no lower threshold for exclusion (pink line) for postinfusion samples. (B) Plasma concentrations were estimated for St Jude Total XV patients on the basis of a simulated dose of 1 g/m<sup>2</sup> methotrexate over 24 hours (solid black line) and COG patients (dotted black line) receiving the same dose. The 1-99th percentile range is shown with shading for the St Jude Total XV patients (blue) and COG patients (red). (C) 4-hour methotrexate infusion of 2 g/m<sup>2</sup>. Concentrations shown were scheduled to be drawn at 4 hours (end of infusion) and at 28 hours (data are jittered for better visualization). (D) Plasma concentrations were estimated for St Jude Total XV patients based on a simulated dose of 2 g/m<sup>2</sup> methotrexate over 4 hours (solid black line) and for COG patients (dotted black line) receiving the same dose. The 1-99th percentile range is shown with shading for the St Jude Total XV patients (blue) and COG patients (red).</p></div></div></div><p id="__p11">Nonlinear mixed-effects modeling (Monolix 3.1; Lixoft) was used to determine population and individual posthoc methotrexate pharmacokinetic parameters. Specifically, a 2-compartment pharmacokinetic model with first-order elimination was fit to the data. The distribution of the parameters (both interoccasion and interindividual) was assumed log-normal. A proportional residual error model was used assuming normal distribution of the residuals. Furthermore, because of the sparse nature of the sampling in the current study, we included as a prior distribution the methotrexate pharmacokinetics from the St Jude Total XV study (supplemental Table 2). For the genome-wide analysis, we used the average methotrexate clearance value per patient.<sup><a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209711">10</a></sup></p><p id="__p12">Germline DNA was isolated at the time of remission from peripheral blood. DNA was extracted and genotyped using the Genome-Wide Human SNP Array 6.0 as described (Affymetrix, Santa Clara, CA).<sup><a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209674">17</a></sup> DNA also was genotyped by the Illumina GoldenGate platform for 7 single-nucleotide polymorphisms (SNP; SNP Center, Johns Hopkins University). We did not perform sequencing or genotype for any rare variants. Genotype calls were coded as 0, 1, or 2 for the number of B alleles (AA, AB, BB). SNPs with a minor allele frequency less than 1% or a call rate less than 95% were excluded. Imputation of SNPs in the 1000 Genomes dataset not represented on the Affymetrix SNP 6.0 array was performed on each ancestral group independently using MACH1.0 (see supplemental Methods).<sup><a href="#B18" rid="B18" class=" bibr popnode">18</a></sup></p><p id="__p13" class="p p-last">A GWAS between germline SNP genotypes and log2-transformed methotrexate clearance was performed with the use of a general linear model assuming an additive effect of allelic dosage, with all models including age, genetic ancestry, sex, and treatment regimen as covariates, as we previously described.<sup><a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209730">10</a>,<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209698">11</a></sup> Genetic ancestry was estimated with STRUCTURE as previously described (see supplemental Methods).<sup><a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209734">17</a></sup> Age was coded in years and treated as a continuous variable. Treatment regimen was coded as a categorical variable. Adjusted methotrexate clearance refers to the residual from a linear regression including the clinical covariates. A meta-analysis was performed by combining the statistics from the current GWAS with those obtained from the GWAS of methotrexate clearance in St Jude patients.<sup><a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209691">10</a></sup> We calculated the combined <em>P</em> values from the meta-analysis using the Stouffer method.<sup><a href="#B19" rid="B19" class=" bibr popnode">19</a>,<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209724">20</a></sup></p></div><div id="__sec3" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec3title">Results</h2><p id="__p14" class="p p-first">We initially tested covariates for their association with methotrexate clearance in a multivariate general linear model (<a href="/pmc/articles/PMC3567337/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). Receipt of the 4-hour (rather than the 24-hour infusion; <em>P</em> &lt; 2 × 10<sup>−16</sup>; <a href="/pmc/articles/PMC3567337/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>A) treatment arm, including a DI phase (<em>P</em> = .0010; supplemental Figure 1), older age (<em>P</em> = 9 × 10<sup>−7</sup>; supplemental Figure 2, consistent with previous reports),<sup><a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209697">10</a></sup> and female sex (<em>P</em> = .000 28, supplemental Figure 3) were all associated with lower clearance. Methotrexate clearance was not related to genetically defined patient ancestry in this study (supplemental Figure 4). In sum, we were able to explain 42.1% of the interindividual variability in methotrexate clearance with the clinical covariates and 1 SNP in <em>SLCO1B1</em>, rs4149056 (<a href="/pmc/articles/PMC3567337/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>), in the same range as in our previous study.<sup><a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209733">11</a></sup></p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p15">Covariates related to methotrexate clearance in a multivariate general linear model</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140360866419280" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th rowspan="1" colspan="1" align="left">Factor</th><th rowspan="1" colspan="1" align="center">Direction</th><th rowspan="1" colspan="1" align="center"><em>P</em><sup>*</sup></th><th rowspan="1" colspan="1" align="center">R<sup>2</sup><sup>*</sup></th><th rowspan="1" colspan="1" align="center"><em>P</em><sup>†</sup></th><th rowspan="1" colspan="1" align="center">R<sup>2</sup><sup>†</sup></th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left">24-hour infusion (vs 4 hour)</td><td rowspan="1" colspan="1" align="left">24-hour higher</td><td rowspan="1" colspan="1" align="center">&lt; 2 × 10<sup>−16</sup></td><td rowspan="1" colspan="1" align="center">38%</td><td rowspan="1" colspan="1" align="center">&lt; 2 × 10<sup>−16</sup></td><td rowspan="1" colspan="1" align="center">38%</td></tr><tr><td rowspan="1" colspan="1" align="left">DI (vs no DI)</td><td rowspan="1" colspan="1" align="left">DI lower</td><td rowspan="1" colspan="1" align="center">.0010</td><td rowspan="1" colspan="1" align="center">0.5%</td><td rowspan="1" colspan="1" align="center">.0022</td><td rowspan="1" colspan="1" align="center">0.4%</td></tr><tr><td rowspan="1" colspan="1" align="left">Age</td><td rowspan="1" colspan="1" align="left">Older lower</td><td rowspan="1" colspan="1" align="center">9 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">1.1%</td><td rowspan="1" colspan="1" align="center">7 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">1.2%</td></tr><tr><td rowspan="1" colspan="1" align="left">Sex</td><td rowspan="1" colspan="1" align="left">Boys greater</td><td rowspan="1" colspan="1" align="center">.00028</td><td rowspan="1" colspan="1" align="center">0.6%</td><td rowspan="1" colspan="1" align="center">.00027</td><td rowspan="1" colspan="1" align="center">0.5%</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4149056 T &gt; C</td><td rowspan="1" colspan="1" align="left">C lower</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">2.1 × 10<sup>−11</sup></td><td rowspan="1" colspan="1" align="center">2%</td></tr></tbody></table></div><div id="largeobj_idm140360866419280" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3567337/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140360863187168"><p id="__p16" class="p p-first-last">DI indicates delayed intensification; direction, direction of association with clearance, ie, those receiving the 24-hour infusion had greater clearance than those receiving the 4-hour infusion; <em>P</em>, association of the factor with average methotrexate clearance based on a multivariate analysis; and R<sup>2</sup>, the amount of interindividual variation explained by each factor.</p></div><div id="TF1-1"><sup>*</sup><em>P</em> and R<sup>2</sup> values for the multivariate model, including infusion length, use of DI, age, and sex.</div><div id="TF1-2"><sup>†</sup><em>P</em> and R<sup>2</sup> value for the multivariate model and also including the rs4149056 genotype.</div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC3567337/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140360856264944" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is zh89991301740003.jpg" title="An external file that holds a picture, illustration, etc.
Object name is zh89991301740003.jpg" src="/pmc/articles/PMC3567337/bin/zh89991301740003.jpg"></div></a><div id="largeobj_idm140360856264944" class="largeobj-link align_right" style=""><a href="/pmc/articles/PMC3567337/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a target="object" href="/pmc/articles/PMC3567337/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC3567337/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p19"><strong>Histogram of each patient's average methotrexate clearance.</strong> (A) Unadjusted methotrexate clearance for the 655 COG patients receiving the 4-hour infusion (blue), and the 624 receiving the 24-hour infusion (red). (B) Methotrexate clearance in all COG patients (n = 1279), adjusted for age, sex, race, and treatment arm (residual from a linear regression model).</p></div></div></div><p id="__p20">When we adjusted for age, sex, and treatment arm, methotrexate clearance displayed a unimodal population distribution (<a href="/pmc/articles/PMC3567337/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>B). A GWAS was performed for SNP-genotype associations with clearance, including age, sex, genetic ancestry, and treatment arm as covariates. The GWAS showed a strong association between methotrexate clearance and SNPs in <em>SLCO1B1</em> (<a href="/pmc/articles/PMC3567337/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>A; <a href="/pmc/articles/PMC3567337/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). There were 4 typed SNPs that reached a genome-wide significance threshold of <em>P</em> &lt; 5 × 10<sup>−8</sup> (rs4149081, rs4149056, rs11045879, and rs11045821). rs4149056 is a nonsynonymous coding SNP that has been shown to have reduced transport of methotrexate in vitro.<sup><a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209702">11</a></sup> Infusion length, treatment including a DI, age, and sex remained significantly associated with clearance in a multivariate model, including the rs4149056 genotype (<a href="/pmc/articles/PMC3567337/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>); it is unclear why there was an association of DI with methotrexate clearance because it persisted after we adjusted for the sex, race, and age factors that might have confounded the association. The other 3 significant SNPs are in linkage disequilibrium (LD) with rs4149056. With each copy of the C allele at rs4149056, the adjusted methotrexate clearance was reduced by 12 mL/min/m<sup>2</sup> (<a href="/pmc/articles/PMC3567337/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>; supplemental Figure 5); thus, clearance is (on average) approximately13% lower in patients with CC versus TT genotypes at rs4149056, a magnitude of difference in exposure that could have significance for efficacy or adverse events.<sup><a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209682">9</a></sup></p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC3567337/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140360860035088" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is zh89991301740004.jpg" title="An external file that holds a picture, illustration, etc.
Object name is zh89991301740004.jpg" src="/pmc/articles/PMC3567337/bin/zh89991301740004.jpg"></div></a><div id="largeobj_idm140360860035088" class="largeobj-link align_right" style=""><a href="/pmc/articles/PMC3567337/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"></a><a target="object" href="/pmc/articles/PMC3567337/figure/F4/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC3567337/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p21"><strong>Manhattan plot of <em>P</em> values for a genome-wide association with methotrexate clearance.</strong> Each chromosome is plotted along the x-axis, whereas the y-axis plots the negative log<sub>10</sub> of the <em>P</em> value for the association of each SNP with methotrexate clearance. Higher points on the graph indicate a stronger association with methotrexate clearance. Typed and imputed SNPs are shown in all panels (5.2 million SNPs). Methotrexate clearance is adjusted for age, sex, race, and treatment arm. (A) Association of each SNP with methotrexate clearance in COG patients (n = 1279). (B) Meta-analysis of St Jude (n = 699) and COG patients (n = 1279). (C) Meta-analysis of St Jude and COG patients, after we adjusted for rs4149056.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p22">Highest ranked SNPs associated with methotrexate clearance in a meta-analysis (typed in 1279 COG patients, typed or imputed in 699 SJ patients)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140360935585392" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th rowspan="1" colspan="1" align="left">rsID</th><th rowspan="1" colspan="1" align="center">Meta <em>P</em></th><th rowspan="1" colspan="1" align="center">A/B alleles</th><th rowspan="1" colspan="1" align="center">Gene</th><th rowspan="1" colspan="1" align="center">COG <em>P</em></th><th rowspan="1" colspan="1" align="center">COG effect size</th><th rowspan="1" colspan="1" align="center">COG source</th><th rowspan="1" colspan="1" align="center">COG B allele freq</th><th rowspan="1" colspan="1" align="center">SJ <em>P</em></th><th rowspan="1" colspan="1" align="center">SJ effect size</th><th rowspan="1" colspan="1" align="center">SJ source</th><th rowspan="1" colspan="1" align="center">SJ B allele freq</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left">rs11045879</td><td rowspan="1" colspan="1" align="center">3.13 × 10<sup>−19</sup></td><td rowspan="1" colspan="1" align="center">T/C</td><td rowspan="1" colspan="1" align="center"><em>SLCO1B1</em></td><td rowspan="1" colspan="1" align="center">8.31 × 10<sup>−10</sup></td><td rowspan="1" colspan="1" align="center">−11.69</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.17</td><td rowspan="1" colspan="1" align="center">6.23 × 10<sup>−11</sup></td><td rowspan="1" colspan="1" align="center">−11.27</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.16</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4149056</td><td rowspan="1" colspan="1" align="center">5.72 × 10<sup>−19</sup></td><td rowspan="1" colspan="1" align="center">T/C</td><td rowspan="1" colspan="1" align="center"><em>SLCO1B1</em></td><td rowspan="1" colspan="1" align="center">2.01 × 10<sup>−10</sup></td><td rowspan="1" colspan="1" align="center">−13.29</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.14</td><td rowspan="1" colspan="1" align="center">4.90 × 10<sup>−10</sup></td><td rowspan="1" colspan="1" align="center">−12.00</td><td rowspan="1" colspan="1" align="center">GoldenGate</td><td rowspan="1" colspan="1" align="center">0.12</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4149081</td><td rowspan="1" colspan="1" align="center">9.74 × 10<sup>−19</sup></td><td rowspan="1" colspan="1" align="center">G/A</td><td rowspan="1" colspan="1" align="center"><em>SLCO1B1</em></td><td rowspan="1" colspan="1" align="center">1.58 × 10<sup>−10</sup></td><td rowspan="1" colspan="1" align="center">−12.19</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.18</td><td rowspan="1" colspan="1" align="center">1.05 × 10<sup>−9</sup></td><td rowspan="1" colspan="1" align="center">−10.61</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.16</td></tr><tr><td rowspan="1" colspan="1" align="left">rs11045813</td><td rowspan="1" colspan="1" align="center">4.04 × 10<sup>−13</sup></td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center"><em>SLCO1B1</em></td><td rowspan="1" colspan="1" align="center">2.95 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">−12.89</td><td rowspan="1" colspan="1" align="center">GoldenGate</td><td rowspan="1" colspan="1" align="center">0.88</td><td rowspan="1" colspan="1" align="center">2.85 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">−9.65</td><td rowspan="1" colspan="1" align="center">GoldenGate</td><td rowspan="1" colspan="1" align="center">0.87</td></tr><tr><td rowspan="1" colspan="1" align="left">rs11045818</td><td rowspan="1" colspan="1" align="center">1.69 × 10<sup>−12</sup></td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center"><em>SLCO1B1</em></td><td rowspan="1" colspan="1" align="center">1.35 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">−11.66</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.88</td><td rowspan="1" colspan="1" align="center">2.63 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">−9.88</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.87</td></tr><tr><td rowspan="1" colspan="1" align="left">rs11045872</td><td rowspan="1" colspan="1" align="center">2.42 × 10<sup>−12</sup></td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center"><em>SLCO1B1</em></td><td rowspan="1" colspan="1" align="center">3.77 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">11.49</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.15</td><td rowspan="1" colspan="1" align="center">1.36 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">8.70</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.15</td></tr><tr><td rowspan="1" colspan="1" align="left">rs11045821</td><td rowspan="1" colspan="1" align="center">5.59 × 10<sup>−12</sup></td><td rowspan="1" colspan="1" align="center">G/A</td><td rowspan="1" colspan="1" align="center"><em>SLCO1B1</em></td><td rowspan="1" colspan="1" align="center">3.33 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" align="center">13.49</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.13</td><td rowspan="1" colspan="1" align="center">2.44 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" align="center">8.46</td><td rowspan="1" colspan="1" align="center">Imputed</td><td rowspan="1" colspan="1" align="center">0.14</td></tr><tr><td rowspan="1" colspan="1" align="left">rs11045870</td><td rowspan="1" colspan="1" align="center">3.81 × 10<sup>−11</sup></td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center"><em>SLCO1B1</em></td><td rowspan="1" colspan="1" align="center">9.17 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">−10.51</td><td rowspan="1" colspan="1" align="center">GoldenGate</td><td rowspan="1" colspan="1" align="center">0.86</td><td rowspan="1" colspan="1" align="center">8.94 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">-8.74</td><td rowspan="1" colspan="1" align="center">GoldenGate</td><td rowspan="1" colspan="1" align="center">0.85</td></tr><tr><td rowspan="1" colspan="1" align="left">rs10841753</td><td rowspan="1" colspan="1" align="center">5.31 × 10<sup>−11</sup></td><td rowspan="1" colspan="1" align="center">T/C</td><td rowspan="1" colspan="1" align="center"><em>SLCO1B1</em></td><td rowspan="1" colspan="1" align="center">6.32 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">8.83</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.21</td><td rowspan="1" colspan="1" align="center">1.89 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">7.87</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.18</td></tr><tr><td rowspan="1" colspan="1" align="left">rs11045892</td><td rowspan="1" colspan="1" align="center">6.60 × 10<sup>−11</sup></td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center"><em>SLCO1B1</em></td><td rowspan="1" colspan="1" align="center">3.27 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" align="center">10.64</td><td rowspan="1" colspan="1" align="center">GoldenGate</td><td rowspan="1" colspan="1" align="center">0.14</td><td rowspan="1" colspan="1" align="center">3.76 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">8.98</td><td rowspan="1" colspan="1" align="center">GoldenGate</td><td rowspan="1" colspan="1" align="center">0.15</td></tr><tr><td rowspan="1" colspan="1" align="left">rs11045825</td><td rowspan="1" colspan="1" align="center">7.80 × 10<sup>−11</sup></td><td rowspan="1" colspan="1" align="center">T/C</td><td rowspan="1" colspan="1" align="center"><em>SLCO1B1</em></td><td rowspan="1" colspan="1" align="center">9.10 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" align="center">12.94</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.13</td><td rowspan="1" colspan="1" align="center">1.16 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">8.12</td><td rowspan="1" colspan="1" align="center">Imputed</td><td rowspan="1" colspan="1" align="center">0.16</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2169969</td><td rowspan="1" colspan="1" align="center">1.67 × 10<sup>−10</sup></td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center"><em>SLCO1B1</em></td><td rowspan="1" colspan="1" align="center">4.35 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">11.75</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.15</td><td rowspan="1" colspan="1" align="center">6.84 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" align="center">8.23</td><td rowspan="1" colspan="1" align="center">Imputed</td><td rowspan="1" colspan="1" align="center">0.17</td></tr><tr><td rowspan="1" colspan="1" align="left">rs16923647</td><td rowspan="1" colspan="1" align="center">7.64 × 10<sup>−10</sup></td><td rowspan="1" colspan="1" align="center">T/C</td><td rowspan="1" colspan="1" align="center"><em>SLCO1A2</em></td><td rowspan="1" colspan="1" align="center">1.31 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">8.98</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.88</td><td rowspan="1" colspan="1" align="center">1.09 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">10.18</td><td rowspan="1" colspan="1" align="center">SNPCHIP</td><td rowspan="1" colspan="1" align="center">0.90</td></tr></tbody></table></div><div id="largeobj_idm140360935585392" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3567337/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140360862930144"><p id="__p23" class="p p-first-last">A/B alleles indicates first allele shown is A, second is B; COG B-allele freq, B-allele frequency in the COG cohort; COG effect size, the change in methotrexate clearance (mL/min/m<sup>2</sup>) with each copy of the B allele in COG cohort; COG <em>P</em>, <em>P</em>-value for COG cohort; COG source, source of SNP genotype data in COG cohort—SNPCHIP (Affymetrix SNP 6.0), GoldenGate (Illumina), or imputed (details in supplemental Methods); Meta <em>P</em>, combined <em>P</em>-values (Stouffer method) from 1279 COG and 699 SJ patients; rsID, dbSNP ID; SJ B allele freq, B-allele frequency in the St Jude cohort; SJ effect size: the change in methotrexate clearance (mL/min/m<sup>2</sup>) with each copy of the B allele in St Jude cohort; SJ <em>P</em>, <em>P</em>-value for St Jude cohort; SJ source, source of SNP genotype data in SJ cohort—SNPCHIP (Affymetrix 500K), GoldenGate (Illumina), or imputed (details in supplemental Methods); and SNP, single-nucleotide polymorphism.</p></div><div id="idm140360863456768"><p id="__p24" class="p p-first-last">All SNPs significantly related to methotrexate clearance (n = 103, typed and imputed) can be found in supplemental Table 3.</p></div></div></div><p id="__p25">In a meta-analysis in which we combined patients treated with the COG and St Jude protocols, <em>SLCO1B1</em> remained significantly related to methotrexate clearance (<a href="/pmc/articles/PMC3567337/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>B). Of the 103 typed or imputed SNPs that reached a Bonferroni-corrected genome-wide significance threshold of <em>P</em> &lt; 9.62 × 10<sup>−9</sup> (supplemental Table 3), 101 were in <em>SLCO1B1</em>. The meta-analysis <em>P</em> value for the top SNP in <em>SLCO1B1</em>, rs4149080, is 5.61 × 10<sup>−21</sup> (supplemental Table 3). This SNP is in LD (r<sup>2</sup> = 0.897) with rs4149056 in European patients and was imputed in both cohorts. The SNP typed in both the COG and St Jude cohorts that had the smallest <em>P</em> value was rs11045879, which is also in LD with rs4149056 (r<sup>2</sup> = 0.865), and had a <em>P</em> value of 3.13 × 10<sup>−19</sup> in the meta-analysis. Two SNPs in <em>SLCO1A2</em> also were related to methotrexate clearance at the genome-wide level (7.6 × 10<sup>−10</sup> and 1.9 × 10<sup>−9</sup>); however, this is most likely because they are very near <em>SLCO1B1</em> on chromosome 12 and in LD with the rs4149056 SNP in <em>SLCO1B1</em> (<a href="/pmc/articles/PMC3567337/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>).<sup><a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209720">21</a>,<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209700">22</a></sup> They are not in LD with the rs11045891 and rs4148981 SNPs that are <em>SLCO1A2</em> enhancers.<sup><a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209715">23</a></sup> SLCO1B3 is a closely related family member that also transports methotrexate.<sup><a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209707">24</a>,<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209679">25</a></sup> Although they did not reach genome-wide significance, 2 SNPs in <em>SLCO1B3</em> were related to methotrexate clearance (<em>P</em> &lt; 3 × 10<sup>−6</sup>), and the association remained after we adjusted for SNPs in <em>SLCO1B1</em>. Four SNPs in <em>SLC19A1</em> (the reduced folate carrier) were interrogated in this study on the Affymetrix array (2 are in LD with functional polymorphisms rs1051266 and rs1131596, r<sup>2</sup> &gt; 0.9), but none reached genome-wide significance for an association with methotrexate clearance.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC3567337/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140360938693088" class="figure"><a href="/pmc/articles/PMC3567337/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3567337_zh89991301740005.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is zh89991301740005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3567337/bin/zh89991301740005.jpg"></a></div><div id="largeobj_idm140360938693088" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3567337/figure/F5/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC3567337/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5</a></div><!--caption a7--><div class="caption"><p id="__p26"><strong>LD of SNPs with <em>P</em> &lt; 10<sup>−5</sup> in meta-analysis spanning <em>SLCO1B3</em>, <em>LST-3TM12</em>, <em>SLCO1B1</em>, and <em>SLCO1A2</em> generated with the use of Haploview software<sup><a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209708">21</a></sup> in European-ancestry patients only (COG n = 806 and SJ n = 459).</strong> The darkness of each box represents the association between 2 SNPs (R<sup>2</sup>), with white being R<sup>2</sup> = 0, black being R<sup>2</sup> = 1, and 0 &lt; R<sup>2</sup> &lt; 1 being shades of gray. LD blocks, highlighted with the yellow lines, were defined by confidence intervals.<sup><a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209727">22</a></sup> Assembly hg18 from <a href="http://genome.ucsc.edu" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://genome.ucsc.edu</a> used for display.</p></div></div></div><p id="__p27" class="p p-last">The nonsynonymous rs4149056 (T521C) SNP has been extensively characterized in relation to other phenotypes<sup><a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209692">26</a><a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209675"></a>–<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209696">28</a></sup> and shown to reduce methotrexate transport in vitro.<sup>11</sup> After we adjusted for the rs4149056 genotype, a significant association remained in <em>SLCO1B1</em> at the genome-wide significance level (<a href="/pmc/articles/PMC3567337/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>C). The SNP with the lowest <em>P</em> value after adjustment for rs4149056 was an intronic SNP, rs4149040 (<em>P</em> = 1.2 × 10<sup>−12</sup>, supplemental Table 4), which is in LD with the nonsynonymous SNP rs2306283. Together, rs2306283 and rs4149056 define the most common haplotypes of <em>SLCO1B1</em> (*1a, *1b, *5, and *15)<sup><a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209726">29</a></sup> and are in partial LD (D′ = 0.91, r<sup>2</sup> = 0.25). As we previously demonstrated, the relationship between methotrexate clearance and rs2306283 genotype is evident only in an analysis stratified for rs4149056 genotype (supplemental Figure 6, <em>P</em> = 4 × 10<sup>−11</sup>),<sup><a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209681">11</a></sup> indicating a highly reproducible SNP-by-SNP interaction. Patients with at least 1 C allele at rs4149056 have lower clearance than those with 2 T alleles (supplemental Figure 5); however, within each rs4149056 genotypic group, the A allele at rs2306283 was associated with even lower clearance, whereas the variant G allele was associated with increased clearance (supplemental Figure 6). We also replicated that the rs11045872 variant G allele was associated with greater methotrexate clearance (<em>P</em> = 3.8 × 10<sup>−7</sup> in COG patients, supplemental Table 3; supplemental Figure 7).</p></div><div id="__sec4" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec4title">Discussion</h2><p id="__p28" class="p p-first">We have replicated the association between <em>SLCO1B1</em> and methotrexate clearance<sup><a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209688">10</a>,<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209735">11</a></sup> with 2 additional schedules of intravenous methotrexate administration in the setting of a cooperative group trial. We estimated methotrexate clearance using 2 plasma methotrexate concentrations per course via a Bayesian pharmacokinetic modeling approach. The mean and range of clearances that we estimated from only 2 plasma concentrations was similar to that estimated from an entirely different group of patients with more samples per course (St Jude Total XV participants).<sup><a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209689">10</a>,<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209718">11</a></sup> Further external validity of methotrexate clearance estimates from these large multicenter trials is provided by the fact that we replicated the association of methotrexate clearance with age, sex, and treatment regimen. We previously found that black patients had the greatest methotrexate clearance<sup><a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209716">10</a></sup>; although this association was not replicated here, there were relatively few black patients (5%) in this COG cohort.</p><p id="__p29">SLCO1B1 is an organic anion transporter that is known to transport methotrexate; minor alleles for SNPs in the <em>SLCO1B1</em> gene are associated with both increased and decreased transporter function and span multiple functional domains in the gene.<sup><a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209680">11</a></sup> We found SNPs associated with both increased and decreased methotrexate clearance in the COG cohort, replicating our previous finding in the St Jude cohort (supplemental Figures 5-7).<sup><a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209690">11</a></sup> We improved our power to detect significant associations by performing a meta-analysis combining the COG and St Jude cohorts. The meta-analysis showed that only SNPs on chromosome 12 near <em>SLCO1B1</em> were related to methotrexate clearance in these patients, many of which were not significant at the genome-wide threshold in either cohort alone. The nonsynonymous rs4149056 (T521C) SNP has been the subject of multiple clinical studies of statins and other agents.<sup><a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209710">26</a>,<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209714">30</a><a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209705"></a><a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209678"></a><a href="#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209694"></a>–<a href="#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209728">34</a></sup> However, even after adjustment for the rs4149056 SNP, other SNPs in <em>SLCO1B1</em> remained significantly related to methotrexate clearance, indicating that there are multiple variants in <em>SLCO1B1</em> that can influence methotrexate clearance. In this independent cohort, we replicated our previous finding, that is, that the rs2306283 G allele was associated with greater clearance after we adjusted for the rs4149056 genotype.<sup><a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209677">11</a></sup></p><p id="__p30">Variants in <em>SLCO1B1</em> could be clinically useful in identifying patients at risk of low methotrexate clearance, particularly in settings in which plasma methotrexate concentrations are not readily available. Toxicity associated with 1 g/m<sup>2</sup> and 2 g/m<sup>2</sup> doses has been reported.<sup><a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209699">35</a>,<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209701">36</a></sup> One possible intervention would be to increase IV hydration and/or alkalinization in the subset of patients with a “low-clearance” <em>SLCO1B1</em> genotype to force greater clearance of methotrexate, but the effects of this intervention on toxicity are not known. Tools for aggregation of <em>SLCO1B1</em> variants into clinically important haplotypes are available (<a href="http://www.pharmgkb.org/gene/PA134865839" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.pharmgkb.org/gene/PA134865839</a>), and such haplotypes are already used for dosing decisions for other drugs, such as statins.<sup><a href="#B37" rid="B37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209719">37</a></sup> In addition, it is likely that the coadministration of HDMTX with other SLCO1B1 substrates or inhibitors will result in increased plasma methotrexate concentrations.<sup><a href="#B38" rid="B38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209684">38</a><a href="#B39" rid="B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209722"></a>–<a href="#B40" rid="B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209693">40</a></sup></p><p id="__p31" class="p p-last">In summary, we have replicated the finding that <em>SLCO1B1</em> is related to methotrexate clearance. This validates our previous GWAS<sup><a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_297209731">10</a></sup> in a separate group of patients who received different dosages of HDMTX in a multi-institutional clinical trial, solidifying the robustness of this pharmacogenomic determinant of methotrexate clearance.</p></div><div id="__sec5" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec5title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="PMC_1">

<!--caption a9--><strong>Supplemental Data, Tables, and Figures:</strong>

<div class="sup-box half_rhythm" id="idm140360902777856"><a href="/pmc/articles/PMC3567337/bin/supp_121_6_898__index.html" data-ga-action="click_feat_suppl">Click here to view.</a></div>

</div></div><div id="idm140360865271472" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140360865271472title">Acknowledgments</h2><div class="sec"><p id="__p34">The authors are grateful to physicians and clinical research associates at the COG institutions participating in this study for cooperation with the sample submission requirements. The authors thank Shaherah Rankins for assistance in preparation of the manuscript.</p><p id="__p35">This work was supported by grants CA 36401, GM 92666, CA 98453, CA98413, <a id="__tag_781388012" class="tag_hotlink" href="/nuccore/CA114766" ref="/nuccore/CA114766"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA114766","term_id":"34968073","term_text":"CA114766"}}</span>CA114766</a>, and CA 21765 from the National Institutes of Health and the American Lebanese Syrian Associated Charities. The authors thank the Jeffrey Pride Foundation and the National Childhood Cancer Foundation for their financial support for genome-wide genotyping of COG specimens. S.P.H. is the Ergen Family Chair in Pediatric Cancer.</p></div></div><div id="idm140360860899008" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140360860899008title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140360860898880"></p><p id="__p32" class="p p-first-last">The online version of this article contains a data supplement.</p><p></p><p class="fn sec" id="idm140360865272672"></p><p id="__p33" class="p p-first-last">The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734.</p><p></p></div></div><div id="__sec6" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec6title">Authorship</h2><!--/article/back/sec/--><p id="__p36" class="p p-first">Contribution: L.B.R., C-H.P., W.E.E., and M.V.R. designed research, analyzed and interpreted data, and drafted the manuscript; J.C.P., C.S., W.Y., Y.F., C.C., and M.D. analyzed and interpreted data and performed statistical analysis; and N.J.W., P.L.M., S.P.H., and M.L. collected, analyzed and interpreted data.</p><p id="__p37">Conflict-of-interest disclosure: The authors declare no competing financial interests.</p><p id="__p38" class="p p-last">Correspondence: Mary V. Relling, PharmD, St Jude Children's Research Hospital, 262 Danny Thomas Place, MS 313, Memphis, TN 38105; e-mail: <a href="mailto:dev@null" data-email="gro.edujts@gniller.yram" class="oemail">gro.edujts@gniller.yram</a>.</p></div><div id="idm140360860372560" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140360860372560title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="element-citation">Whitehead VM, Shuster JJ, Vuchich MJ, et al.  Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. <span><span class="ref-journal">Leukemia. </span>2005;<span class="ref-vol">19</span>(4):533–536.</span> [<a href="/pubmed/15716987" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Accumulation+of+methotrexate+and+methotrexate+polyglutamates+in+lymphoblasts+and+treatment+outcome+in+children+with+B-progenitor-cell+acute+lymphoblastic+leukemia:+a+Pediatric+Oncology+Group+study.&amp;author=VM+Whitehead&amp;author=JJ+Shuster&amp;author=MJ+Vuchich&amp;volume=19&amp;issue=4&amp;publication_year=2005&amp;pages=533-536&amp;pmid=15716987&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="element-citation">Asselin BL, Devidas M, Wang C, et al.  Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404). <span><span class="ref-journal">Blood. </span>2011;<span class="ref-vol">118</span>(4):874–883.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3292437/">PMC free article</a>]</span> [<a href="/pubmed/21474675" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Effectiveness+of+high-dose+methotrexate+in+T-cell+lymphoblastic+leukemia+and+advanced-stage+lymphoblastic+lymphoma:+a+randomized+study+by+the+Children's+Oncology+Group+(POG+9404).&amp;author=BL+Asselin&amp;author=M+Devidas&amp;author=C+Wang&amp;volume=118&amp;issue=4&amp;publication_year=2011&amp;pages=874-883&amp;pmid=21474675&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="element-citation">Clarke M, Gaynon P, Hann I, et al.  CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials. <span><span class="ref-journal">J Clin Oncol. </span>2003;<span class="ref-vol">21</span>(9):1798–1809.</span> [<a href="/pubmed/12721257" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=CNS-directed+therapy+for+childhood+acute+lymphoblastic+leukemia:+Childhood+ALL+Collaborative+Group+overview+of+43+randomized+trials.&amp;author=M+Clarke&amp;author=P+Gaynon&amp;author=I+Hann&amp;volume=21&amp;issue=9&amp;publication_year=2003&amp;pages=1798-1809&amp;pmid=12721257&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="element-citation">Matloub Y, Bostrom BC, Hunger SP, et al.  Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. <span><span class="ref-journal">Blood. </span>2011;<span class="ref-vol">118</span>(2):243–251.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3138679/">PMC free article</a>]</span> [<a href="/pubmed/21562038" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Escalating+intravenous+methotrexate+improves+event-free+survival+in+children+with+standard-risk+acute+lymphoblastic+leukemia:+a+report+from+the+Children's+Oncology+Group.&amp;author=Y+Matloub&amp;author=BC+Bostrom&amp;author=SP+Hunger&amp;volume=118&amp;issue=2&amp;publication_year=2011&amp;pages=243-251&amp;pmid=21562038&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="element-citation">Mikkelsen TS, Sparreboom A, Cheng C, et al.  Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial. <span><span class="ref-journal">J Clin Oncol. </span>2011;<span class="ref-vol">29</span>(13):1771–1778.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3107765/">PMC free article</a>]</span> [<a href="/pubmed/21444869" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Shortening+infusion+time+for+high-dose+methotrexate+alters+antileukemic+effects:+a+randomized+prospective+clinical+trial.&amp;author=TS+Mikkelsen&amp;author=A+Sparreboom&amp;author=C+Cheng&amp;volume=29&amp;issue=13&amp;publication_year=2011&amp;pages=1771-1778&amp;pmid=21444869&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="element-citation">Borowitz MJ, Devidas M, Hunger SP, et al.  Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. <span><span class="ref-journal">Blood. </span>2008;<span class="ref-vol">111</span>(12):5477–5485.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2424148/">PMC free article</a>]</span> [<a href="/pubmed/18388178" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Clinical+significance+of+minimal+residual+disease+in+childhood+acute+lymphoblastic+leukemia+and+its+relationship+to+other+prognostic+factors:+a+Children's+Oncology+Group+study.&amp;author=MJ+Borowitz&amp;author=M+Devidas&amp;author=SP+Hunger&amp;volume=111&amp;issue=12&amp;publication_year=2008&amp;pages=5477-5485&amp;pmid=18388178&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="element-citation">Xu H, Cheng C, Devidas M, et al.  ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. <span><span class="ref-journal">J Clin Oncol. </span>2012;<span class="ref-vol">30</span>(7):751–757.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3295551/">PMC free article</a>]</span> [<a href="/pubmed/22291082" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=ARID5B+genetic+polymorphisms+contribute+to+racial+disparities+in+the+incidence+and+treatment+outcome+of+childhood+acute+lymphoblastic+leukemia.&amp;author=H+Xu&amp;author=C+Cheng&amp;author=M+Devidas&amp;volume=30&amp;issue=7&amp;publication_year=2012&amp;pages=751-757&amp;pmid=22291082&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="element-citation">Evans WE, Crom WR, Stewart CF, et al.  Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia. <span><span class="ref-journal">Lancet. </span>1984;<span class="ref-vol">1</span>:359–362.</span> [<a href="/pubmed/6141424" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Methotrexate+systemic+clearance+influences+probability+of+relapse+in+children+with+standard-risk+acute+lymphocytic+leukaemia.&amp;author=WE+Evans&amp;author=WR+Crom&amp;author=CF+Stewart&amp;volume=1&amp;publication_year=1984&amp;pages=359-362&amp;pmid=6141424&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="element-citation">Evans WE, Crom WR, Abromowitch M, et al.  Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect. <span><span class="ref-journal">N Engl J Med. </span>1986;<span class="ref-vol">314</span>(8):471–477.</span> [<a href="/pubmed/3456079" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Clinical+pharmacodynamics+of+high-dose+methotrexate+in+acute+lymphocytic+leukemia.+Identification+of+a+relation+between+concentration+and+effect.&amp;author=WE+Evans&amp;author=WR+Crom&amp;author=M+Abromowitch&amp;volume=314&amp;issue=8&amp;publication_year=1986&amp;pages=471-477&amp;pmid=3456079&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="element-citation">Trevino LR, Shimasaki N, Yang W, et al.  Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. <span><span class="ref-journal">J Clin Oncol. </span>2009;<span class="ref-vol">27</span>(35):5972–5978.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2793040/">PMC free article</a>]</span> [<a href="/pubmed/19901119" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Germline+genetic+variation+in+an+organic+anion+transporter+polypeptide+associated+with+methotrexate+pharmacokinetics+and+clinical+effects.&amp;author=LR+Trevino&amp;author=N+Shimasaki&amp;author=W+Yang&amp;volume=27&amp;issue=35&amp;publication_year=2009&amp;pages=5972-5978&amp;pmid=19901119&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="element-citation">Ramsey LB, Bruun GH, Yang W, et al.  Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. <span><span class="ref-journal">Genome Res. </span>2012;<span class="ref-vol">22</span>(1):1–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3246196/">PMC free article</a>]</span> [<a href="/pubmed/22147369" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Res&amp;title=Rare+versus+common+variants+in+pharmacogenetics:+SLCO1B1+variation+and+methotrexate+disposition.&amp;author=LB+Ramsey&amp;author=GH+Bruun&amp;author=W+Yang&amp;volume=22&amp;issue=1&amp;publication_year=2012&amp;pages=1-8&amp;pmid=22147369&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="element-citation">Shuster J, Camitta B, Pullen J, et al.  Identification of newly diagnosed children with acute lymphocytic leukemia at high risk for relapse. <span><span class="ref-journal">Cancer Res Ther Control. </span>1999;<span class="ref-vol">9</span>(1):101–107.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res+Ther+Control&amp;title=Identification+of+newly+diagnosed+children+with+acute+lymphocytic+leukemia+at+high+risk+for+relapse.&amp;author=J+Shuster&amp;author=B+Camitta&amp;author=J+Pullen&amp;volume=9&amp;issue=1&amp;publication_year=1999&amp;pages=101-107&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="element-citation">Garre ML, Relling MV, Kalwinsky D, et al.  Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemia. <span><span class="ref-journal">J Pediatr. </span>1987;<span class="ref-vol">111</span>:606–612.</span> [<a href="/pubmed/2958611" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pediatr&amp;title=Pharmacokinetics+and+toxicity+of+methotrexate+in+children+with+Down+syndrome+and+acute+lymphocytic+leukemia.&amp;author=ML+Garre&amp;author=MV+Relling&amp;author=D+Kalwinsky&amp;volume=111&amp;publication_year=1987&amp;pages=606-612&amp;pmid=2958611&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="element-citation">Dordelmann M, Schrappe M, Reiter A, et al.  Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Munster Group. <span><span class="ref-journal">Leukemia. </span>1998;<span class="ref-vol">12</span>(5):645–651.</span> [<a href="/pubmed/9593260" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Down's+syndrome+in+childhood+acute+lymphoblastic+leukemia:+clinical+characteristics+and+treatment+outcome+in+four+consecutive+BFM+trials.+Berlin-Frankfurt-Munster+Group.&amp;author=M+Dordelmann&amp;author=M+Schrappe&amp;author=A+Reiter&amp;volume=12&amp;issue=5&amp;publication_year=1998&amp;pages=645-651&amp;pmid=9593260&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="element-citation">Buitenkamp TD, Mathot RA, de Haas V, Pieters R, Zwaan CM. Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia. <span><span class="ref-journal">Haematologica. </span>2010;<span class="ref-vol">95</span>(7):1106–1113.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2895034/">PMC free article</a>]</span> [<a href="/pubmed/20418240" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Haematologica&amp;title=Methotrexate-induced+side+effects+are+not+due+to+differences+in+pharmacokinetics+in+children+with+Down+syndrome+and+acute+lymphoblastic+leukemia.&amp;author=TD+Buitenkamp&amp;author=RA+Mathot&amp;author=V+de+Haas&amp;author=R+Pieters&amp;author=CM+Zwaan&amp;volume=95&amp;issue=7&amp;publication_year=2010&amp;pages=1106-1113&amp;pmid=20418240&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="element-citation">Panetta JC, Sparreboom A, Pui CH, Relling MV, Evans WE. Modeling mechanisms of in vivo variability in methotrexate accumulation and folate pathway inhibition in acute lymphoblastic leukemia cells. <span><span class="ref-journal">PLoS Comput Biol. </span>2010;<span class="ref-vol">6</span>(12):e1001019.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2996318/">PMC free article</a>]</span> [<a href="/pubmed/21152005" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Comput+Biol&amp;title=Modeling+mechanisms+of+in+vivo+variability+in+methotrexate+accumulation+and+folate+pathway+inhibition+in+acute+lymphoblastic+leukemia+cells.&amp;author=JC+Panetta&amp;author=A+Sparreboom&amp;author=CH+Pui&amp;author=MV+Relling&amp;author=WE+Evans&amp;volume=6&amp;issue=12&amp;publication_year=2010&amp;pages=e1001019&amp;pmid=21152005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="element-citation">Yang JJ, Cheng C, Devidas M, et al.  Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>(3):237–241.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3104508/">PMC free article</a>]</span> [<a href="/pubmed/21297632" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Ancestry+and+pharmacogenomics+of+relapse+in+acute+lymphoblastic+leukemia.&amp;author=JJ+Yang&amp;author=C+Cheng&amp;author=M+Devidas&amp;volume=43&amp;issue=3&amp;publication_year=2011&amp;pages=237-241&amp;pmid=21297632&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="element-citation">Li Y, Abecasis GR. Mach 1.0: Rapid haplotype reconstruction and missing genotype inference. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">S79</span>:2290.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Mach+1.0:+Rapid+haplotype+reconstruction+and+missing+genotype+inference.&amp;author=Y+Li&amp;author=GR+Abecasis&amp;volume=S79&amp;publication_year=2006&amp;pages=2290&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="element-citation">Stouffer SA, Suchman EA, DeVinney LC, Star SA, Williams RM., Jr . <span class="ref-journal">Adjustment During Army Life.</span> Princeton, NJ: Princeton University Press; 1949.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Adjustment+During+Army+Life&amp;author=SA+Stouffer&amp;author=EA+Suchman&amp;author=LC+DeVinney&amp;author=SA+Star&amp;author=RM+Williams&amp;publication_year=1949&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="element-citation">Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. <span><span class="ref-journal">Bioinformatics. </span>2010;<span class="ref-vol">26</span>(17):2190–2191.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2922887/">PMC free article</a>]</span> [<a href="/pubmed/20616382" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=METAL:+fast+and+efficient+meta-analysis+of+genomewide+association+scans.&amp;author=CJ+Willer&amp;author=Y+Li&amp;author=GR+Abecasis&amp;volume=26&amp;issue=17&amp;publication_year=2010&amp;pages=2190-2191&amp;pmid=20616382&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="element-citation">Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. <span><span class="ref-journal">Bioinformatics. </span>2005;<span class="ref-vol">21</span>(2):263–265.</span> [<a href="/pubmed/15297300" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Haploview:+analysis+and+visualization+of+LD+and+haplotype+maps.&amp;author=JC+Barrett&amp;author=B+Fry&amp;author=J+Maller&amp;author=MJ+Daly&amp;volume=21&amp;issue=2&amp;publication_year=2005&amp;pages=263-265&amp;pmid=15297300&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="element-citation">Gabriel SB, Schaffner SF, Nguyen H, et al.  The structure of haplotype blocks in the human genome. <span><span class="ref-journal">Science. </span>2002;<span class="ref-vol">296</span>(5576):2225–2229.</span> [<a href="/pubmed/12029063" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+structure+of+haplotype+blocks+in+the+human+genome.&amp;author=SB+Gabriel&amp;author=SF+Schaffner&amp;author=H+Nguyen&amp;volume=296&amp;issue=5576&amp;publication_year=2002&amp;pages=2225-2229&amp;pmid=12029063&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="element-citation">Kim MJ, Skewes-Cox P, Fukushima H, et al.  Functional characterization of liver enhancers that regulate drug-associated transporters. <span><span class="ref-journal">Clin Pharmacol Ther. </span>2011;<span class="ref-vol">89</span>(4):571–578.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3227682/">PMC free article</a>]</span> [<a href="/pubmed/21368754" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;title=Functional+characterization+of+liver+enhancers+that+regulate+drug-associated+transporters.&amp;author=MJ+Kim&amp;author=P+Skewes-Cox&amp;author=H+Fukushima&amp;volume=89&amp;issue=4&amp;publication_year=2011&amp;pages=571-578&amp;pmid=21368754&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="element-citation">Abe T, Unno M, Onogawa T, et al.  LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. <span><span class="ref-journal">Gastroenterology. </span>2001;<span class="ref-vol">120</span>(7):1689–1699.</span> [<a href="/pubmed/11375950" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=LST-2,+a+human+liver-specific+organic+anion+transporter,+determines+methotrexate+sensitivity+in+gastrointestinal+cancers.&amp;author=T+Abe&amp;author=M+Unno&amp;author=T+Onogawa&amp;volume=120&amp;issue=7&amp;publication_year=2001&amp;pages=1689-1699&amp;pmid=11375950&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="element-citation">Chae YJ, Lee KR, Noh CK, et al.  Functional consequences of genetic variations in the human organic anion transporting polypeptide 1B3 (OATP1B3) in the Korean population. <span><span class="ref-journal">J Pharm Sci. </span>2012;<span class="ref-vol">101</span>(3):1302–1313.</span> [<a href="/pubmed/22147445" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Sci&amp;title=Functional+consequences+of+genetic+variations+in+the+human+organic+anion+transporting+polypeptide+1B3+(OATP1B3)+in+the+Korean+population.&amp;author=YJ+Chae&amp;author=KR+Lee&amp;author=CK+Noh&amp;volume=101&amp;issue=3&amp;publication_year=2012&amp;pages=1302-1313&amp;pmid=22147445&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="element-citation">Link E, Parish S, Armitage J, et al.  SLCO1B1 variants and statin-induced myopathy—a genomewide study. <span><span class="ref-journal">N Engl J Med. </span>2008;<span class="ref-vol">359</span>(8):789–799.</span> [<a href="/pubmed/18650507" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=SLCO1B1+variants+and+statin-induced+myopathy—a+genomewide+study.&amp;author=E+Link&amp;author=S+Parish&amp;author=J+Armitage&amp;volume=359&amp;issue=8&amp;publication_year=2008&amp;pages=789-799&amp;pmid=18650507&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="element-citation">Deng JW, Song IS, Shin HJ, et al.  The effects of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15. <span><span class="ref-journal">Pharmacogenet Genomics. </span>2008;<span class="ref-vol">18</span>(5):424–433.</span> [<a href="/pubmed/18408565" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenet+Genomics&amp;title=The+effects+of+SLCO1B1*15+on+the+disposition+of+pravastatin+and+pitavastatin+is+substrate+dependent:+the+contribution+of+transporting+activity+changes+by+SLCO1B1*15.&amp;author=JW+Deng&amp;author=IS+Song&amp;author=HJ+Shin&amp;volume=18&amp;issue=5&amp;publication_year=2008&amp;pages=424-433&amp;pmid=18408565&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="element-citation">Xiang X, Jada SR, Li HH, et al.  Pharmacogenetics of SLCO1B1 gene and the impact of *1b and *15 haplotypes on irinotecan disposition in Asian cancer patients. <span><span class="ref-journal">Pharmacogenet Genomics. </span>2006;<span class="ref-vol">16</span>(9):683–691.</span> [<a href="/pubmed/16906022" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenet+Genomics&amp;title=Pharmacogenetics+of+SLCO1B1+gene+and+the+impact+of+*1b+and+*15+haplotypes+on+irinotecan+disposition+in+Asian+cancer+patients.&amp;author=X+Xiang&amp;author=SR+Jada&amp;author=HH+Li&amp;volume=16&amp;issue=9&amp;publication_year=2006&amp;pages=683-691&amp;pmid=16906022&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="element-citation">Pasanen MK, Neuvonen PJ, Niemi M. Global analysis of genetic variation in SLCO1B1. <span><span class="ref-journal">Pharmacogenomics. </span>2008;<span class="ref-vol">9</span>(1):19–33.</span> [<a href="/pubmed/18154446" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics&amp;title=Global+analysis+of+genetic+variation+in+SLCO1B1.&amp;author=MK+Pasanen&amp;author=PJ+Neuvonen&amp;author=M+Niemi&amp;volume=9&amp;issue=1&amp;publication_year=2008&amp;pages=19-33&amp;pmid=18154446&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="element-citation">Johnson AD, Kavousi M, Smith AV, et al.  Genome- wide association meta-analysis for total serum bilirubin levels. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>(14):2700–2710.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2701336/">PMC free article</a>]</span> [<a href="/pubmed/19414484" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Mol+Genet&amp;title=Genome-+wide+association+meta-analysis+for+total+serum+bilirubin+levels.&amp;author=AD+Johnson&amp;author=M+Kavousi&amp;author=AV+Smith&amp;volume=18&amp;issue=14&amp;publication_year=2009&amp;pages=2700-2710&amp;pmid=19414484&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="element-citation">Innocenti F, Kroetz DL, Schuetz E, et al.  Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. <span><span class="ref-journal">J Clin Oncol. </span>2009;<span class="ref-vol">27</span>(16):2604–2614.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2690389/">PMC free article</a>]</span> [<a href="/pubmed/19349540" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Comprehensive+pharmacogenetic+analysis+of+irinotecan+neutropenia+and+pharmacokinetics.&amp;author=F+Innocenti&amp;author=DL+Kroetz&amp;author=E+Schuetz&amp;volume=27&amp;issue=16&amp;publication_year=2009&amp;pages=2604-2614&amp;pmid=19349540&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="element-citation">Kalliokoski A, Neuvonen M, Neuvonen PJ, Niemi M. Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide. <span><span class="ref-journal">J Clin Pharmacol. </span>2008;<span class="ref-vol">48</span>(3):311–321.</span> [<a href="/pubmed/18187595" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;title=Different+effects+of+SLCO1B1+polymorphism+on+the+pharmacokinetics+and+pharmacodynamics+of+repaglinide+and+nateglinide.&amp;author=A+Kalliokoski&amp;author=M+Neuvonen&amp;author=PJ+Neuvonen&amp;author=M+Niemi&amp;volume=48&amp;issue=3&amp;publication_year=2008&amp;pages=311-321&amp;pmid=18187595&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="element-citation">Ni W, Ji J, Dai Z, et al.  Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition. <span><span class="ref-journal">PLoS One. </span>2010;<span class="ref-vol">5</span>(11):e13792.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2967470/">PMC free article</a>]</span> [<a href="/pubmed/21072184" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Flavopiridol+pharmacogenetics:+clinical+and+functional+evidence+for+the+role+of+SLCO1B1/OATP1B1+in+flavopiridol+disposition.&amp;author=W+Ni&amp;author=J+Ji&amp;author=Z+Dai&amp;volume=5&amp;issue=11&amp;publication_year=2010&amp;pages=e13792&amp;pmid=21072184&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="element-citation">Pasanen MK, Neuvonen M, Neuvonen PJ, Niemi M. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. <span><span class="ref-journal">Pharmacogenet Genomics. </span>2006;<span class="ref-vol">16</span>(12):873–879.</span> [<a href="/pubmed/17108811" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenet+Genomics&amp;title=SLCO1B1+polymorphism+markedly+affects+the+pharmacokinetics+of+simvastatin+acid.&amp;author=MK+Pasanen&amp;author=M+Neuvonen&amp;author=PJ+Neuvonen&amp;author=M+Niemi&amp;volume=16&amp;issue=12&amp;publication_year=2006&amp;pages=873-879&amp;pmid=17108811&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="element-citation">Camitta B, Mahoney D, Leventhal B, et al.  Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: a Pediatric Oncology Group study. <span><span class="ref-journal">J Clin Oncol. </span>1994;<span class="ref-vol">12</span>:1383–1389.</span> [<a href="/pubmed/8021728" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Intensive+intravenous+methotrexate+and+mercaptopurine+treatment+of+higher-risk+non-T,+non-B+acute+lymphocytic+leukemia:+a+Pediatric+Oncology+Group+study.&amp;author=B+Camitta&amp;author=D+Mahoney&amp;author=B+Leventhal&amp;volume=12&amp;publication_year=1994&amp;pages=1383-1389&amp;pmid=8021728&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="element-citation">Kishi S, Cheng C, French D, et al.  Ancestry and pharmacogenetics of antileukemic drug toxicity. <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">109</span>(10):4151–4157.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1885506/">PMC free article</a>]</span> [<a href="/pubmed/17264302" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Ancestry+and+pharmacogenetics+of+antileukemic+drug+toxicity.&amp;author=S+Kishi&amp;author=C+Cheng&amp;author=D+French&amp;volume=109&amp;issue=10&amp;publication_year=2007&amp;pages=4151-4157&amp;pmid=17264302&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="element-citation">Wilke RA, Ramsey LB, Johnson SG, et al.  The clinical pharmacogenomics implementation consortium: CPIC Guideline for SLCO1B1 and simvastatin-induced myopathy. <span><span class="ref-journal">Clin Pharmacol Ther. </span>2012;<span class="ref-vol">92</span>(1):112–117.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3384438/">PMC free article</a>]</span> [<a href="/pubmed/22617227" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;title=The+clinical+pharmacogenomics+implementation+consortium:+CPIC+Guideline+for+SLCO1B1+and+simvastatin-induced+myopathy.&amp;author=RA+Wilke&amp;author=LB+Ramsey&amp;author=SG+Johnson&amp;volume=92&amp;issue=1&amp;publication_year=2012&amp;pages=112-117&amp;pmid=22617227&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="element-citation">Niemi M, Pasanen MK, Neuvonen PJ. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. <span><span class="ref-journal">Pharmacol Rev. </span>2011;<span class="ref-vol">63</span>(1):157–181.</span> [<a href="/pubmed/21245207" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Rev&amp;title=Organic+anion+transporting+polypeptide+1B1:+a+genetically+polymorphic+transporter+of+major+importance+for+hepatic+drug+uptake.&amp;author=M+Niemi&amp;author=MK+Pasanen&amp;author=PJ+Neuvonen&amp;volume=63&amp;issue=1&amp;publication_year=2011&amp;pages=157-181&amp;pmid=21245207&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="element-citation">Karlgren M, Ahlin G, Bergstrom CA, Svensson R, Palm J, Artursson P. In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions. <span><span class="ref-journal">Pharm Res. </span>2012;<span class="ref-vol">29</span>(2):411–426.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3264873/">PMC free article</a>]</span> [<a href="/pubmed/21861202" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res&amp;title=In+vitro+and+in+silico+strategies+to+identify+OATP1B1+inhibitors+and+predict+clinical+drug-drug+interactions.&amp;author=M+Karlgren&amp;author=G+Ahlin&amp;author=CA+Bergstrom&amp;author=R+Svensson&amp;author=J+Palm&amp;volume=29&amp;issue=2&amp;publication_year=2012&amp;pages=411-426&amp;pmid=21861202&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="element-citation">Fox RI, Morgan SL, Smith HT, Robbins BA, Choc MG, Baggott JE. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels compared with methotrexate alone. <span><span class="ref-journal">Rheumatology (Oxford) </span>2003;<span class="ref-vol">42</span>(8):989–994.</span> [<a href="/pubmed/12730515" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatology+(Oxford)&amp;title=Combined+oral+cyclosporin+and+methotrexate+therapy+in+patients+with+rheumatoid+arthritis+elevates+methotrexate+levels+and+reduces+7-hydroxymethotrexate+levels+compared+with+methotrexate+alone.&amp;author=RI+Fox&amp;author=SL+Morgan&amp;author=HT+Smith&amp;author=BA+Robbins&amp;author=MG+Choc&amp;volume=42&amp;issue=8&amp;publication_year=2003&amp;pages=989-994&amp;pmid=12730515&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3567337&amp;issue-id=219402&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140360869786512title">Key Points</a></li><li><a href="#idm140360868939904title">Abstract</a></li><li><a href="#__sec1title">Introduction</a></li><li><a href="#__sec2title">Methods</a></li><li><a href="#__sec3title">Results</a></li><li><a href="#__sec4title">Discussion</a></li><li><a href="#__sec5title">Supplementary Material</a></li><li><a href="#idm140360865271472title">Acknowledgments</a></li><li><a href="#idm140360860899008title">Footnotes</a></li><li><a href="#__sec6title">Authorship</a></li><li><a href="#idm140360860372560title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Blood</span> are provided here courtesy of <strong>The American Society of Hematology</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3567337/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3567337/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3567337/?report=printable">Printer Friendly</a></li> | <li><a href="#" data-citationid="PMC3567337" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3567337%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3567337%2F&amp;text=Genome-wide%20study%20of%20methotrexate%20clearance%20replicates%20SLCO1B1" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3567337%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="23233662" data-aiid="3567337" data-aid="3567337" data-iid="219402" data-domainid="446" data-domain="blood" data-accid="PMC3567337" data-md5="182e08b8d4821dcd53bcc73f0afe006e"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T10:01:51-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal103&amp;ncbi_phid=CE8A4BB9DD54B74100000000073204BE&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3567337%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=blood&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3567337/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>